Blank Martin, Goodman Reba M
Physiology and Cellular Biophysics, Columbia University , 630 W 168 St, New York, NY 10032 , USA.
Electromagn Biol Med. 2012 Dec;31(4):243-9. doi: 10.3109/15368378.2011.624662. Epub 2012 Jun 7.
We propose a biologically based measure of EMF radiation to replace the energy-based "specific absorption rate" (SAR). A wide range of EMF frequencies has been linked to an increased risk of cancer. The SAR value used to measure the EMF dose and set the safety standard in the radiofrequency (RF) range fails as a standard for predicting cancer risk in the ELF power frequency range. Because cancers are believed to arise from mutations in DNA, changes in DNA induced by interaction with EMF could be a better measure of the biologically effective dose in both frequency ranges. The changes can be measured by transcriptional alterations and/or translational changes in specific proteins. Because ionizing radiation also causes DNA damage, a biologically based standard related to stimulation of DNA could apply over a much wider range of the electromagnetic spectrum. A safety standard for exposure to a wide range of non ionizing frequencies can be based on the documented changes in DNA biochemistry that arise from interactions with EMF.
我们提出一种基于生物学的电磁辐射测量方法,以取代基于能量的“比吸收率”(SAR)。多种电磁频率已被证明与癌症风险增加有关。用于测量电磁剂量并设定射频(RF)范围内安全标准的SAR值,在预测极低频(ELF)工频范围内的癌症风险时,无法作为标准使用。由于癌症被认为源于DNA突变,与电磁相互作用引起的DNA变化可能是两个频率范围内生物学有效剂量的更好衡量标准。这些变化可以通过特定蛋白质的转录改变和/或翻译变化来测量。由于电离辐射也会导致DNA损伤,与DNA刺激相关的基于生物学的标准可以适用于更广泛的电磁频谱范围。针对广泛的非电离频率暴露的安全标准,可以基于与电磁相互作用引起的DNA生物化学记录变化。